Clinical Trials in Atlanta

Showing 9641-9660 of 19,805 trials

QuikClot Control+ Hemostatic Dressing Use in Mild to Moderate Bleeding

NCT04415606

QuikClot Control+ Hemostatic Dressing (QuikClot+) is indicated for temporary control of internal organ space bleeding for patients displaying Class III or Class IV Bleeding. It may also be used for control of severely bleeding wounds such as surgical wounds and traumatic injuries. QuikClot Control+ is also indicated for temporary control of mild to moderate bleeding in cardiac surgical procedures. QuikClot Control+ is also indicated for use to control bleeding from bone surface following sternotomy.

Hemostasis

Z-Medica266 participantsStarted Jun 2020

Aurora, Colorado, United States • Atlanta, Georgia, United States • Pocatello, Idaho, United States +4 more locations

COMPLETEDPhase 2< 1 mile

Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age

NCT03698279

The objectives of this study were: * To describe the safety of each dosage of high-dose quadrivalent influenza vaccine (QIV-HD) used in the study during the 28 days following each vaccination, and serious adverse events (including adverse events of special interest throughout the study). * To describe the antibody response induced by each dosage of QIV-HD used in the study compared with unadjuvanted standard-dose quadrivalent influenza vaccine (QIV-SD) by hemagglutination inhibition (HAI) measurement method. * To describe the antibody response induced by each dosage of QIV-HD used in the study compared with unadjuvanted QIV-SD by virus seroneutralization (SN) measurement method. * To describe the antibody response induced by the highest acceptable dosage of QIV-HD compared with adjuvanted trivalent influenza vaccine (TIV) by HAI and virus SN measurement methods.

Influenza

Sanofi Pasteur, a Sanofi Company665 participantsStarted Oct 2018

San Diego, California, United States • Miami, Florida, United States • Atlanta, Georgia, United States +13 more locations

QuikClot Control+ Hemostatic Dressing Use in Mild to Moderate Bleeding

Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age

Find Trials by Condition in Atlanta

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

Reducing Involuntary Movements in Participants With Tardive Dyskinesia

A Study of Oral Contraception Under Simulated OTC Conditions

Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure

NSABP Patient Registry and Biospecimen Profiling Repository

Neuroimaging Biomarker for Seizures

Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps

Repeat Antenatal Steroids Trial

Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status

Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors

Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants.

CV-SQuISH-ED: Clinical Validation Study

Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate

Post Market Study of the 3DKnee™ With E-plus Insert

Combination Study for High Risk Multiple Myeloma Patients